ClinicalTrials.gov
public full text
Public Domain
Safety and Efficacy of PG101 for Dry Eye Syndrome
To evaluate the safety and efficacy of 0.25% PG101 and 1.0% PG101 topical gel suspension compared to placebo when administered two times daily for 14 days in subjects diagnosed with dry eye syndrome
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Safety, Efficacy, Tolerability and Pharmacokinetics of AGN-223575 Ophthalmic Suspension in Patients With Dry Eye Disease#993242
- A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye#803594
- Phase III Clinical Study of Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease#863337
- Efficacy and Safety Study of ATs in Patients With Dry Eye Syndrome#848613
- A Study to Determine the Relief of Dry Eye Symptoms With the Use of TheraTears® Products (DUNLIN)#832505
Record · ID 1243523
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive